Biobanking: Technologies and Global Markets

Feb 2022| BIO084C| BCC Publishing
Sample Report

Report Highlights

The global market for biobanking is estimated to increase from $61.1 billion in 2021 to $76.2 billion by 2026, at a compound annual growth rate (CAGR) of 4.5% during 2021-2026.

Report Includes

  • 22 data tables and 29 additional tables
  • An up-to-date review and analysis of the global markets for biobanking technologies
  • Analyses of the global market trends, with data from 2019-2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Highlights of the upcoming market potential for biobanking technologies, and areas of focus to forecast this market into various segments and sub-segments
  • In-depth information (facts and figures) concerning market drivers, market deterrents and other demographic and economic factors that will drive future demand for biobanking products
  • Evaluation and forecast the overall market size for biobanks, forecasted growth trends, and corresponding market share analysis by sample type, application, ownership type, and region
  • Identification of novel biobanking products and promising new technologies still in the development and testing stage and assess the probability that they will be commercialized successfully in the next five years
  • Review of emerging companies and the leading competitors in the prevailing biobanking industry
  • Insight into recent patent activities on biobanking techniques, R&D activities, clinical trials under process, and selected list of biobanking studies
  • Descriptive company profiles of the major global players, including Agilent Technologies Inc., AstraZeneca plc, Bruker Corp., Hamilton Co., Merck KGaA, Qiagen N.V., and Thermo Fisher Scientific Inc.

Report Scope

This report aims to provide a comprehensive study of the global market for biobanking. It provides a detailed description of the different types of biobanks (disease-oriented/clinical based and population-based) worldwide. The biobanking market is segmented based on their application as basic/scientific research and clinical research/therapeutics. Each application segments’ historical and projected market revenues are provided in the report. The global market for biobanking is also segmented based on sample type (as biofluids, tissue, stem cells, DNA/RNA and others) and ownership types (government agencies/public sector providers, academic institutes/universities, non-profit organizations and private organizations). The market revenue for each geographical segment, including North America, Europe, Asia-Pacific and Rest of the World (ROW), have also been provided in the report.

For an in-depth understanding of the market, profiles of market participants are also part of this report. This report also discusses driving and restraining factors and key trends in the biobanking market.

This research covers biobanks dealing with basic science and clinical research. Forensic science, paternity testing, cryopreservation facilities or screening disease testing for newborns and fertility clinics dealing with ovum, sperm and embryo biobanks are not covered in this report. Transplantation and graft-related biobanks dealing with heart valves, cornea and cartilage/tendon are also not covered. Tissue banks for orthopedic, spine, dental, maxillofacial surgery and stem cells biobank for regenerative medicine are also not covered in this report.

Frequently Asked Questions (FAQs)

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2020
Forecast period considered 2021-2026
Base year market size $58.5 billion
Market size forecast $76.1 billion
Growth rate CAGR of 4.5% from 2021 to 2026
Units considered $ Millions
Segments covered Sample Type, Application, Ownership Type
Regions covered North America, Europe, Asia-Pacific, Rest of the World (RoW)
Countries covered U.S., Canada, Germany, France, U.K., Italy, Sweden, Spain, Switzerland, Denmark, Norway, Poland, Belgium, Austria, Netherlands, Russia, Japan, China, Australia, South Korea, India, New Zealand, Taiwan, Singapore, Malaysia, Thailand, Philippines, Indonesia, Latin America, Middle East and Africa
Key Market Drivers
  • Increasing Public Funding in Biobank Projects
  • Increasing Applications in Drug Discovery and Development
  • Increasing Pharmaceutical and Biotech R&D Spending
  • Developments in Analytical Technologies and Assay Methods
  • Growing Focus on Mainstream Precision Medicine and Rise of Genomic Medicine/Clinical Genomics
  • Biobanking Technique Advancements
  • Growing Private Biobanking
Companies studied

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
. Title/Chapter NamePagesPrice Member Price
Full Report: Biobanking: Technologies and Global Markets138 $2,750 Free
Chapter- 1: Introduction6Free DownloadFree
Chapter- 2: Summary and Highlights4$250Free
Chapter- 3: Market and Technology Background12$243Free
Chapter- 4: Current Biobanks Worldwide19$384Free
Chapter- 5: Analysis of Market Opportunities13$263Free
Chapter- 6: Market Breakdown by Sample Type6$121Free
Chapter- 7: Market Breakdown by Application11$222Free
Chapter- 8: Market Breakdown by Region24$485Free
Chapter- 9: Market Breakdown by Ownership Type7$142Free
Chapter- 10: Patent Review/New Developments10$202Free
Chapter- 11: Company Profiles24$485Free
Chapter- 12: Appendix: Acronyms2$40Free
Published - Nov-2016| Analyst - Jackson Highsmith| Code - BIO084B

Report Highlights

The global market for biobanking technologies was valued at $186.3 billion in 2015. This market is expected to increase from $198.2 billion in 2016 to $240.2 billion in 2021 at a compound annual growth rate (CAGR) of 3.9% for 2016-2021.

Report Includes

  • An overview of the global markets for biobanking, the storage of biological samples for the future.
  • Analyses of global market trends, with data from 2015, estimates for 2016 and projections of compound annual growth rates (CAGRs) through 2021.
  • Detailed analyses of how biobanks can lead to new products for specific diseases to overall industry trends.
  • Breakdowns of the biobanking market by product, disease category, and geographic region or country.
  • New products approved by the FDA, and those products expected to be approved within the forecast period.
  • Analysis of the leading competitors, as well as emerging companies in the current worldwide biobanking market.
  • Profiles of the manufacturers of leading products, and their specific product strategies are outlined.
Published - Jun-2011| Analyst - Jackson Highsmith| Code - BIO084A

Report Highlights

The global biobanking market was $141 billion in 2010 and is projected to increase by 30% between 2010 and 2015, at a compound annual growth rate (CAGR) of 5.4%.

Biobanking: Technologies and Global Markets

Single User License: $2750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.